Categories: World

BRIEF-Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab With HB1801 For Her2+ Advanced Breast Cancer

Aug 18 (Reuters) – Alphamab Oncology: * NMPA ACCEPTS NDA FOR ANBENITAMAB (KN026) WITH HB1801 FOR HER2+ ADVANCED BREAST CANCER Further company coverage:(The article has been published through…

Add NewsX As A Trusted Source
Add as a preferred
source on Google
Published by
Published: August 18, 2026 15:49:05 IST

Aug 18 (Reuters) – Alphamab Oncology: * NMPA ACCEPTS NDA FOR ANBENITAMAB (KN026) WITH HB1801 FOR HER2+ ADVANCED BREAST CANCER Further company coverage:

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Published by
Published: August 18, 2026 15:49:05 IST

Recent Posts

US stock futures fall as fading Iran peace prospects drive up oil, yields

By Shashwat Chauhan and Purvi Agarwal Aug 18 (Reuters) - Futures tied to the S&P…

August 18, 2026

Sharon Stone, comedian Ramy Youssef to star in film 'Martha & Muhammad'

Washington DC [US], August 18 (ANI): Comedian Ramy Youssef and actress Sharon Stone will star…

August 18, 2026

Ohtani homers twice as Dodgers rout Rockies 11-5

VIDEO SHOWS: HIGHLIGHTS FROM LOS ANGELES DODGERS V COLORADO ROCKIES MLB GAME RESENDING WITH COMPLETE…

August 18, 2026